122 related articles for article (PubMed ID: 36564258)
21. The additive value of mpMRI on prostate cancer detection: Comparison between patients with and without a suspicious digital rectal examination (DRE).
Omri N; Alex S; Jacob B; Ofer N
Urol Oncol; 2021 Oct; 39(10):728.e7-728.e11. PubMed ID: 33454199
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of abbreviated multiparametric MRI-derived protocols in predicting local staging of prostate cancer in men undergoing radical prostatectomy.
Giannarini G; Cereser L; Como G; Bonato F; Pizzolitto S; Valotto C; Ficarra V; Dal Moro F; Zuiani C; Girometti R
Acta Radiol; 2021 Jul; 62(7):949-958. PubMed ID: 32718179
[TBL] [Abstract][Full Text] [Related]
23. Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging.
Meijer D; van Leeuwen PJ; Donswijk ML; Boellaard TN; Schoots IG; van der Poel HG; Hendrikse HN; Oprea-Lager DE; Vis AN
BJU Int; 2022 Jan; 129(1):54-62. PubMed ID: 34028165
[TBL] [Abstract][Full Text] [Related]
24. Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.
Zanelli E; Giannarini G; Cereser L; Zuiani C; Como G; Pizzolitto S; Crestani A; Valotto C; Ficarra V; Girometti R
J Magn Reson Imaging; 2019 Nov; 50(5):1604-1613. PubMed ID: 30957321
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of digital rectal exam for the existence of advanced pathologic features after prostatectomy.
Prebay ZJ; Medairos R; Doolittle J; Langenstroer P; Jacobsohn K; See WA; Johnson SC
Prostate; 2021 Oct; 81(14):1064-1070. PubMed ID: 34297858
[TBL] [Abstract][Full Text] [Related]
26. A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy.
Orczyk C; Rosenkrantz AB; Deng FM; Melamed J; Babb J; Wysock J; Kheterpal E; Huang WC; Stifelman M; Lepor H; Taneja SS
Urol Oncol; 2016 Jan; 34(1):3.e1-8. PubMed ID: 26338414
[TBL] [Abstract][Full Text] [Related]
27. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation.
Porreca A; D'Agostino D; Vigo M; Corsi P; Romagnoli D; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Giampaoli M
Arch Ital Urol Androl; 2020 Jan; 91(4):224-229. PubMed ID: 31937084
[TBL] [Abstract][Full Text] [Related]
28. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation.
Stokes SH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):129-36. PubMed ID: 10758314
[TBL] [Abstract][Full Text] [Related]
29. Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy.
Lee LW; McBain CA; Swindell R; Wylie JP; Cowan RA; Logue JP
Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):517-22. PubMed ID: 15630843
[TBL] [Abstract][Full Text] [Related]
30. Who Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?
Morote J; Celma A; Roche S; de Torres IM; Mast R; Semedey ME; Regis L; Planas J
Eur Urol Oncol; 2019 Nov; 2(6):664-669. PubMed ID: 31411977
[TBL] [Abstract][Full Text] [Related]
31. Prospective analysis of the diagnostic accuracy of digital rectal examination and magnetic resonance imaging for T staging of prostate cancer.
Zhu J; Wu X; Xue Y; Li X; Zheng Q; Xue X; Huang Z; Chen S
J Cancer Res Ther; 2023 Aug; 19(4):1024-1030. PubMed ID: 37675732
[TBL] [Abstract][Full Text] [Related]
32. Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI.
Achard V; Lamanna G; Denis A; De Perrot T; Mainta IC; Ratib O; Iselin C; Miralbell R; Garibotto V; Zilli T
Med Oncol; 2019 Jun; 36(8):67. PubMed ID: 31190232
[TBL] [Abstract][Full Text] [Related]
33. Multiparametric Magnetic Resonance Imaging Should Be Preferred Over Digital Rectal Examination for Prostate Cancer Local Staging and Disease Risk Classification.
Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
Urology; 2021 Jan; 147():205-212. PubMed ID: 33129868
[TBL] [Abstract][Full Text] [Related]
34. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Parker CC; Clarke NW; Cook AD; Kynaston HG; Petersen PM; Catton C; Cross W; Logue J; Parulekar W; Payne H; Persad R; Pickering H; Saad F; Anderson J; Bahl A; Bottomley D; Brasso K; Chahal R; Cooke PW; Eddy B; Gibbs S; Goh C; Gujral S; Heath C; Henderson A; Jaganathan R; Jakobsen H; James ND; Kanaga Sundaram S; Lees K; Lester J; Lindberg H; Money-Kyrle J; Morris S; O'Sullivan J; Ostler P; Owen L; Patel P; Pope A; Popert R; Raman R; Røder MA; Sayers I; Simms M; Wilson J; Zarkar A; Parmar MKB; Sydes MR
Lancet; 2020 Oct; 396(10260):1413-1421. PubMed ID: 33002429
[TBL] [Abstract][Full Text] [Related]
35. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
36. Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade.
Venkatesan AM; Mudairu-Dawodu E; Duran C; Stafford RJ; Yan Y; Wei W; Kundra V
Cancer Imaging; 2021 Jan; 21(1):3. PubMed ID: 33407861
[TBL] [Abstract][Full Text] [Related]
37. A magnetic resonance imaging-based nomogram for predicting clinically significant prostate cancer at radical prostatectomy.
Castellani D; Cecchini S; Mazzucchelli R; Soraci L; Di Rosa M; Fabbietti P; Palagonia E; Puccio F; Carnevali F; Paci E; Montironi R; Galosi AB
Urol Oncol; 2022 Aug; 40(8):379.e1-379.e8. PubMed ID: 35662497
[TBL] [Abstract][Full Text] [Related]
38. Incremental Impact of [
Szigeti F; Schweighofer-Zwink G; Meissnitzer M; Hauser-Kronberger C; Hitzl W; Kunit T; Forstner R; Pirich C; Beheshti M
Mol Imaging Biol; 2022 Feb; 24(1):50-59. PubMed ID: 34519966
[TBL] [Abstract][Full Text] [Related]
39. [Prostate cancer development after transurethral resection of the prostate--histopathological studies of radical prostatectomy specimens].
Kanno H; Umemoto S; Izumi K; Hasumi H; Osada Y; Ohta J; Mikata K; Tuchiya F
Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):649-59. PubMed ID: 16768146
[TBL] [Abstract][Full Text] [Related]
40. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
